Barings’s PDL BioPharma, Inc. PDLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-64,400
Closed -$189K 985
2018
Q1
$189K Hold
64,400
﹤0.01% 890
2017
Q4
$176K Hold
64,400
﹤0.01% 929
2017
Q3
$218K Hold
64,400
﹤0.01% 823
2017
Q2
$159K Sell
64,400
-64,400
-50% -$148K ﹤0.01% 827
2017
Q1
$292K Buy
128,800
+64,400
+100% +$142K ﹤0.01% 984
2016
Q4
$137K Hold
64,400
﹤0.01% 859
2016
Q3
$216K Hold
64,400
0.01% 747
2016
Q2
$202K Sell
64,400
-25,400
-28% -$84.7K 0.01% 862
2016
Q1
$299K Buy
89,800
+26,700
+42% +$83.2K 0.01% 808
2015
Q4
$223K Hold
63,100
0.01% 850
2015
Q3
$317K Buy
63,100
+52,400
+490% +$300K 0.01% 744
2015
Q2
$69K Hold
10,700
﹤0.01% 961
2015
Q1
$75K Sell
10,700
-1,500
-12% -$10.9K ﹤0.01% 950
2014
Q4
$94K Hold
12,200
﹤0.01% 923
2014
Q3
$91K Sell
12,200
-4,200
-26% -$39K ﹤0.01% 939
2014
Q2
$159K Sell
16,400
-2,200
-12% -$19.6K ﹤0.01% 943
2014
Q1
$155K Hold
18,600
﹤0.01% 895
2013
Q4
$157K Sell
18,600
-3,100
-14% -$26.1K 0.01% 891
2013
Q3
$173K Buy
+21,700
New +$174K 0.01% 895

Other funds holding PDLI